$15.22
0.533.61%
At close: Feb 18, 4:00 PM EST
$15.22
N/A
After Hours: 4:00 PM EST
Comments
Loading...
Contineum Therapeutics Inc Earnings Estimates
CTNMNASDAQ
Contineum Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CTNM
Contineum Therapeutics (CTNM) is scheduled to report Q4 earnings on March 5, 2026. Analysts estimate EPS of $-0.43 and quarterly revenue of $5.00M.
In the most recent quarter (Q3), Contineum Therapeutics reported EPS of $-0.45, beating estimates of $-0.51 by 0.12%. Revenue came in at $0.00, missing the estimate of $5.00M by 1.00%.
Over the last 4 quarters, Contineum Therapeutics has averaged an EPS surprise of 0.20% and a revenue surprise of 1.00%.
Earnings Date
Mar 5
EPS Estimate
$-0.430
Quarterly Revenue Estimate
$5.00M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Contineum Therapeutics Earnings History
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
Contineum Therapeutics (CTNM) Earnings Per Share
The chart below shows Contineum Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $-0.45 | $-0.51 | 11.8 % |
| Q2 | 2025-08-05 | $-0.62 | $-0.47 | -31.9 % |
| Q1 | 2025-05-14 | $-0.62 | $-0.57 | -8.77 % |
| Q4 | 2025-03-06 | $-0.56 | $-0.44 | -27.3 % |
Contineum Therapeutics (CTNM) Revenue
The chart below shows Contineum Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $0 | $5.00M | -100.0 % |
| Q2 | 2025-08-05 | $0 | $6.00M | -100.0 % |
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics (CTNM) is scheduled to report earnings on May 13, 2026. The last reported earnings were for reported on October 30, 2025 for Q3.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
The Actual EPS was $-0.45, which beat the estimate of $-0.51.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
The Actual Revenue was $0.00, which missed the estimate of $5.00M.
